Intricate chromatograms with many major peaks propose contamination, degradation items, or synthesis byproducts remaining in the ultimate merchandise. Some compounding pharmacies declare they use legal workarounds or exemptions. These claims lack merit. No regulatory pathway permits retatrutide compounding right now. Multiple endocrine neopla